Cargando…
_version_ 1783665426682609664
author Pison, Christophe
Shah, Pallav L.
Slebos, Dirk‑Jan
Ninane, Vincent
Janssens, Wim
Perez, Thierry
Kessler, Romain
Deslee, Gaetan
Garner, Justin L.
Hartman, Jorine E.
Degano, Bruno
Mayr, Anna
Mayse, Martin
Peterson, Alexander D.
Valipour, Arschang
author_facet Pison, Christophe
Shah, Pallav L.
Slebos, Dirk‑Jan
Ninane, Vincent
Janssens, Wim
Perez, Thierry
Kessler, Romain
Deslee, Gaetan
Garner, Justin L.
Hartman, Jorine E.
Degano, Bruno
Mayr, Anna
Mayse, Martin
Peterson, Alexander D.
Valipour, Arschang
author_sort Pison, Christophe
collection PubMed
description
format Online
Article
Text
id pubmed-7962218
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79622182021-03-16 Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes Pison, Christophe Shah, Pallav L. Slebos, Dirk‑Jan Ninane, Vincent Janssens, Wim Perez, Thierry Kessler, Romain Deslee, Gaetan Garner, Justin L. Hartman, Jorine E. Degano, Bruno Mayr, Anna Mayse, Martin Peterson, Alexander D. Valipour, Arschang Respir Res Correction BioMed Central 2021-03-15 2021 /pmc/articles/PMC7962218/ /pubmed/33722230 http://dx.doi.org/10.1186/s12931-021-01678-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Pison, Christophe
Shah, Pallav L.
Slebos, Dirk‑Jan
Ninane, Vincent
Janssens, Wim
Perez, Thierry
Kessler, Romain
Deslee, Gaetan
Garner, Justin L.
Hartman, Jorine E.
Degano, Bruno
Mayr, Anna
Mayse, Martin
Peterson, Alexander D.
Valipour, Arschang
Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
title Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
title_full Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
title_fullStr Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
title_full_unstemmed Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
title_short Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
title_sort correction to: safety of denervation following targeted lung denervation therapy for copd: airflow-1 3-year outcomes
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962218/
https://www.ncbi.nlm.nih.gov/pubmed/33722230
http://dx.doi.org/10.1186/s12931-021-01678-z
work_keys_str_mv AT pisonchristophe correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT shahpallavl correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT slebosdirkjan correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT ninanevincent correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT janssenswim correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT perezthierry correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT kesslerromain correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT desleegaetan correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT garnerjustinl correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT hartmanjorinee correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT deganobruno correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT mayranna correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT maysemartin correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT petersonalexanderd correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes
AT valipourarschang correctiontosafetyofdenervationfollowingtargetedlungdenervationtherapyforcopdairflow13yearoutcomes